Missing Diversity In Brain Tumor Trials Apr 10 Written by William Ellis William Ellis Previous Previous Woman With Glioblastoma Brain Cancer Hikes Grand Canyon For The 11th Time Next Next Servier, A Global Pharmaceutical Group, Announced Groundbreaking Results From Their Phase 3 Indigo Clinical Trial
